-
公开(公告)号:US20210118525A1
公开(公告)日:2021-04-22
申请号:US17253833
申请日:2019-06-20
Applicant: Jamie Evan Craig , The Flinders University of South Australia , The Council of the Queensland Institute of Medical Research , University of Tasmania , Southern Adelaide Local Health Network
Inventor: Jamie Evan Craig , Stuart MacGregor , Alex William Hewitt
Abstract: The present disclosure relates to methods and systems for assessing the risk of glaucoma in a subject. In certain embodiments, the present disclosure provide a method of assessing the risk of primary open angle glaucoma in a subject, the method comprises determining a risk score for primary open angle glaucoma in the subject on the basis of the genetic content of the subject at a plurality of selected genetic loci or markers and thereby assessing the risk of primary open angle glaucoma in the subject, wherein the selected genetic loci or markers comprise (i) genetic loci or markers having an association with glaucoma, and/or (ii) genetic loci or markers having an association with increased intraocular pressure, and/or (iii) genetic loci or markers having an association with an increased vertical cup to disk ratio, and/or (iv) genetic loci or markers having an association with a multi-trait test of glaucoma, intraocular pressure and vertical cup to disc ratio. Other embodiments are described.
-
公开(公告)号:US20200209124A1
公开(公告)日:2020-07-02
申请号:US16614961
申请日:2018-05-21
Applicant: UNIVERSITY OF TASMANIA
Inventor: Elisenda Fornells Vernet , Michael Charles Breadmore
Abstract: The present invention relates to an evaporative membrane concentration device adapted to interface two liquid flow processes, such as two low or high resolution separation techniques or a low or high resolution separation technique and a liquid flow detection technique. For example, the two liquid flow processes may be a liquid chromatography technique and a liquid flow detection technique or a multi-dimensional separation technique, for example, two dimensional liquid chromatography (LC×LC) or solvent extraction, such as liquid-liquid extraction or solid phase extraction, with a liquid chromatography technique (LLE or SPE-LC). Methods of using the device and separation and/or chromatographic methods using the device are also described.
-
公开(公告)号:US20170219523A1
公开(公告)日:2017-08-03
申请号:US15515249
申请日:2015-09-30
Applicant: UNIVERSITY OF TASMANIA
IPC: G01N27/447 , B01D17/06 , G01N15/02 , G01N33/487 , B01L3/00 , G01N1/40 , B01D63/00 , B01D71/50
CPC classification number: G01N27/44791 , B01D17/06 , B01D61/18 , B01D63/005 , B01D71/50 , B01L3/50273 , B01L3/502753 , B01L2300/0864 , B01L2400/0421 , G01N1/40 , G01N1/4005 , G01N15/0266 , G01N15/0272 , G01N27/44704 , G01N27/44743 , G01N33/48721 , G01N2001/4038
Abstract: A device for extracting and concentrating a target analyte including a sample channel that receives the sample, a separation channel, a waste channel, a first junction between the sample channel and the separation channel, and, a second junction between the separation channel and the waste channel. The first junction selectively transports a first group of analytes, including target analytes, from the sample channel to the separation channel in accordance with a size of a first free transport region of the first junction. The second junction selectively transports a second group of analytes from the separation channel to the waste channel in accordance with a size of a second free transport region of the second junction, the second group being a subset of the first group, so as to concentrate a number of the target analytes in the separation channel.
-
公开(公告)号:US11135384B2
公开(公告)日:2021-10-05
申请号:US15774946
申请日:2016-11-10
Applicant: University of Tasmania
Inventor: Timothy John Gale , Peter Anderson Dargaville
Abstract: Provided herein is a method for automatically controlling inspired oxygen delivery, including: receiving signals representing a plurality of input oxygen saturation (SpO2) values for a patient; generating control values based on the input SpO2 values and a target SpO2 value; and generating output inspired oxygen concentration (FiO2) values based on the control values and reference inspired oxygen concentration (rFiO2) values; wherein the control values include: immediate control values, generated based on the input SpO2 values, the target SpO2 value, and an immediate gain coefficient; accumulation control values, generated based on the input SpO2 values, the target SpO2 value, and an accumulation gain coefficient; and predictive control values, generated based on the input SpO2 values, the target SpO2 value, and a predictive gain coefficient; wherein the immediate gain coefficient is determined based on the rFiO2 value; and wherein a non-linear compensation weighting is applied to the accumulation control value based on a predetermined non-linear relationship between partial pressure of arterial oxygen (PaO2) and SpO2.
-
公开(公告)号:US20210138002A1
公开(公告)日:2021-05-13
申请号:US17251135
申请日:2019-06-12
Applicant: UNIVERSITY OF TASMANIA
Inventor: Rajamaran Eri , Gordon Edwards , Kent John Neil Taylor , Roger Anthony Stanley , Tanvi Sandesh Shinde
IPC: A61K35/742 , A23L33/125 , A23L33/135 , A23L33/22 , A23L2/52 , A61K36/899
Abstract: The invention relates to the field of food supplement manufacture and therapeutic manufacture. In particular, the invention relates to use of a prebiotic whole plant fibre extract from sugarcane in the diet of an individual for the prophylaxis and/or treatment of Inflammatory Bowel Disease. The invention also relates to a combination of the prebiotic whole plant fibre extract from sugarcane and probiotic strains, the synbiotic use of said combination in the diet of an individual, and the improved outcomes of the synbiotic approach in the prophylaxis and/or treatment of Inflammatory Bowel Disease.
-
公开(公告)号:US20140179614A1
公开(公告)日:2014-06-26
申请号:US14086233
申请日:2013-11-21
Applicant: University of Tasmania
Inventor: Vladimir Berezin , Elisabeth Bock , Milena Penkowa
IPC: C07K7/08
CPC classification number: C07K14/825 , A61K38/00 , C07K7/08
Abstract: The present invention relates to neural cell survival, differentiation and proliferation promoting peptide fragments derived from metallothioneins (MT), pharmaceutical compositions comprising said peptide fragments and uses thereof for treatment of diseases and conditions where the effects of stimulating neural cell proliferation, differentiation and/or survival, and/or stimulating neural plasticity associated with learning and memory are beneficial for treatment.
Abstract translation: 本发明涉及来自金属硫蛋白(MT)的神经细胞存活,分化和增殖促进肽片段,包含所述肽片段的药物组合物及其用于治疗刺激神经细胞增殖,分化和/或 生存和/或刺激与学习和记忆相关的神经可塑性有益于治疗。
-
公开(公告)号:US11590463B2
公开(公告)日:2023-02-28
申请号:US16626212
申请日:2018-06-28
Applicant: University of Tasmania
Inventor: Robert Shellie , Masoomeh Tehrani Rokh , Marcel Van Den Bronk
IPC: B01F31/441 , B01F23/40 , G01N1/38 , B01F23/43 , B01F23/451 , B01F35/75
Abstract: A liquid-liquid mixing device (10, 210) includes a barrel (20, 220) with a liquid port (23) at or adjacent one end. A plunger assembly (30) is reciprocably moveable along an axis in the barrel (20, 220) and includes a seal member (31, 231) and an agitator (50, 250). The seal member (31, 231) is in sealingly slidable engagement with the internal wall of the barrel (20, 220) to define a variable volume chamber (24, 224) therein in communication with the liquid port. The agitator (50, 250) is reciprocably moveable in the variable volume chamber (24, 224), which agitator (50, 250) includes one or more end to end passages (54) through which liquid in the chamber (24, 224) is forced as the agitator (250) reciprocates in the chamber (24, 224). The device (10) also includes a mode selector mechanism (60, 28, 46, 64, 65, 90, 92, 94, 96) for selection between at least two modes of operation for the plunger assembly, wherein the mode selector mechanism (60, 28, 46, 64, 65, 90, 92, 94, 96) is adjustable between two or more modes whereby movement of the plunger assembly (30) effects either movement of the agitator (50, 250) with the seal member (31, 231) or movement of the agitator (50, 250) relative to the seal member (31, 231), depending on the selected mode.
-
公开(公告)号:US11278225B2
公开(公告)日:2022-03-22
申请号:US15751664
申请日:2016-08-12
Applicant: University of Tasmania
Inventor: David Charles Bailey , Andrew Gooley , Florian Germain Lapierre , David John Melville , Rod Anthony Wiebenga , Chau Hoang Thanh Nguyen , Eugen Meyer
Abstract: A pen format liquid collection device includes an elongate generally tubular housing (12, 112, 212, 312) able to be held by hand and having an opening at one end, and at least one liquid take-up element (30, 130, 230, 330) mounted in the housing so as to be positioned or positionable to project at the opening, the at least one liquid take-up element then further postionable by hand manipulation of the housing to contact a volume of liquid to thereby take-up a sample of the liquid to be analysed. At least one retention element (230a, 330a) is supported in the housing. The at least one liquid take-up element and the at least one retention element are arranged whereby they are relatively movable into contact, and the at least one retention element is adapted on contact to in turn take-up the sample and retain the sample or a component thereof for in situ analysis or later recovery while protected within the housing. The liquid take-up element is preferably a capillary.
-
公开(公告)号:US10306883B2
公开(公告)日:2019-06-04
申请号:US14151689
申请日:2014-01-09
Applicant: UNIVERSITY OF TASMANIA
Inventor: Emily Frances Hilder , Wei Boon Hon
Abstract: The present invention generally relates to the use of porous polymer materials as a medium for the storage of biological samples. The present invention also relates to a method of drying and storage of biological samples on the porous polymer materials. The biological samples include blood and blood plasma samples.
-
公开(公告)号:US10100100B2
公开(公告)日:2018-10-16
申请号:US15377059
申请日:2016-12-13
Applicant: University of Tasmania
Inventor: Vladimir Berezin , Elisabeth Bock , Milena Penkowa
IPC: A61K38/00 , A61K39/00 , A61K35/30 , C07K14/825 , C07K7/08
Abstract: The present invention relates to neural cell survival, differentiation and proliferation promoting peptide fragments derived from metallothioneins (MT), pharmaceutical compositions comprising said peptide fragments and uses thereof for treatment of diseases and conditions where the effects of stimulating neural cell proliferation, differentiation and/or survival, and/or stimulating neural plasticity associated with learning and memory are beneficial for treatment.
-
-
-
-
-
-
-
-
-